HDAC inhibition as a therapeutic potential to treat metabolic diseases
| Contribuinte(s) |
McGee, Sean Walder, Ken |
|---|---|
| Data(s) |
01/08/2013
|
| Resumo |
Type 2 diabetes is one of the leading threats to human health. The research focused to identify new drugs that could partly mimic the positive effects of exercise and to test whether these drugs could have the potential to treat metabolic diseases such as obesity and type 2 diabetes |
| Identificador | |
| Idioma(s) |
eng |
| Publicador |
Deakin University, Faculty of Health, School of Medicine |
| Relação |
http://dro.deakin.edu.au/eserv/DU:30066170/gaur-agreement-2014.pdf http://dro.deakin.edu.au/eserv/DU:30066170/gaur-hdacinhibition-2014A.pdf |
| Direitos |
The author |
| Palavras-Chave | #type 2 diabetes #obesity #drug treatment #HDAC inhibition #muscle metabolism |
| Tipo |
Thesis |
